Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05504681 · ClinicalTrials.gov registry record
Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic
A clinical trial of Neurocognitive Disorders, sponsored by Baptist Health South Florida.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT05504681 is a study of Neurocognitive Disorders that is actively recruiting participants, run by Baptist Health South Florida. The registered enrollment target is 200 participants, below the 581-participant average among 8 other Neurocognitive Disorders trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05504681, a study of Neurocognitive Disorders, is actively recruiting participants, sponsored by Baptist Health South Florida.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is prospective observational registry study that will assess 1) if the neurocognitive function app (Brainlab Cognition) can be used in a widespread neuro-oncology clinic setting and 2) if patient reported quality of life parameters can be obtained electronically and integrated into clinic.
Conditions Studied
Interventions
- OTHER Observational study
Study Locations (1)
Florida
- Miami Cancer Institute - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-11-30 |
| Est. Completion | 2027-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05504681
The ClinicalTrials.gov registry entry for NCT05504681 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 581-participant average among 8 other Neurocognitive Disorders trials with a reported enrollment target (66% lower). The listed sponsor is Baptist Health South Florida, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neurocognitive Disorders appearing as the primary indexed condition, and to 1 intervention - of which Observational study is the first listed.
NCT05504681 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05504681 about?
NCT05504681 is a clinical study titled "Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic". This is prospective observational registry study that will assess 1) if the neurocognitive function app (Brainlab Cognition) can be used in a widespread neuro-oncology clinic setting and 2) if patient reported quality of life parameters can be obtained electronically and integrated into clinic.
What is the current status of trial NCT05504681?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2021-11-30. Estimated completion is 2027-11.
What conditions does trial NCT05504681 study?
This clinical trial studies the following conditions: Neurocognitive Disorders.
What interventions are being tested in trial NCT05504681?
The interventions under investigation include: Observational study (OTHER).
Who is sponsoring clinical trial NCT05504681?
This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05504681 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurocognitive Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study
RECRUITING · Phase 4
-
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
RECRUITING · NA
-
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
RECRUITING
-
A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)
ACTIVE NOT RECRUITING · Phase 3
-
A Pilot Randomized Controlled Trial: CoINTEGRATE
COMPLETED · NA
-
Development of the Pediatric Neurocognitive Functioning Questionnaire
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.